Here is the new application developed by Boehringer Ingelheim France, "the heart of the FA." It assists you in evaluating the thromboembolic and hemorrhagic risk in the assessment of renal function.

Here is the new application developed by Boehringer Ingelheim France, "the heart of the FA." It assists you in evaluating the thromboembolic and hemorrhagic risk in the assessment of renal function.

less